Literature DB >> 21157378

Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.

Grant W Simmons1, Winnie W Pong, Ryan J Emnett, Crystal R White, Scott M Gianino, Fausto J Rodriguez, David H Gutmann.   

Abstract

Whereas carcinogenesis requires the acquisition of driver mutations in progenitor cells, tumor growth and progression are heavily influenced by the local microenvironment. Previous studies from our laboratory have used Neurofibromatosis-1 (NF1) genetically engineered mice to characterize the role of stromal cells and signals to optic glioma formation and growth. Previously, we have shown that Nf1+/- microglia in the tumor microenvironment are critical cellular determinants of optic glioma proliferation. To define the role of microglia in tumor formation and maintenance further, we used CD11b-TK mice, in which resident brain microglia (CD11b+, CD68+, Iba1+, CD45low cells) can be ablated at specific times after ganciclovir administration. Ganciclovir-mediated microglia reduction reduced Nf1 optic glioma proliferation during both tumor maintenance and tumor development. We identified the developmental window during which microglia are increased in the Nf1+/- optic nerve and demonstrated that this accumulation reflected delayed microglia dispersion. The increase in microglia in the Nf1+/- optic nerve was associated with reduced expression of the chemokine receptor, CX3CR1, such that reduced Cx3cr1 expression in Cx3cr1-GFP heterozygous knockout mice led to a similar increase in optic nerve microglia. These results establish a critical role for microglia in the development and maintenance of Nf1 optic glioma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21157378      PMCID: PMC3044783          DOI: 10.1097/NEN.0b013e3182032d37

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  61 in total

1.  Distribution of the CD68 macrophage/myeloid associated antigen.

Authors:  K A Pulford; A Sipos; J L Cordell; W P Stross; D Y Mason
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the beta1 integrin subunit.

Authors:  Clotilde Lauro; Myriam Catalano; Flavia Trettel; Fabrizio Mainiero; Maria Teresa Ciotti; Fabrizio Eusebi; Cristina Limatola
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  Distribution and characterization of microglia/macrophages in human brain tumors.

Authors:  W Roggendorf; S Strupp; W Paulus
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

4.  CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

Authors:  Janka Held-Feindt; Kirsten Hattermann; Susanne Sebens Müerköster; Hanna Wedderkopp; Friederike Knerlich-Lukoschus; Hendrik Ungefroren; H Maximilian Mehdorn; Rolf Mentlein
Journal:  Exp Cell Res       Date:  2010-02-23       Impact factor: 3.905

5.  Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.

Authors:  Yuan Zhu; Takayuki Harada; Li Liu; Mark E Lush; Frantz Guignard; Chikako Harada; Dennis K Burns; M Livia Bajenaru; David H Gutmann; Luis F Parada
Journal:  Development       Date:  2005-12       Impact factor: 6.868

6.  Isolation of murine microglial cells for RNA analysis or flow cytometry.

Authors:  Astrid E Cardona; DeRen Huang; Margaret E Sasse; Richard M Ransohoff
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

7.  Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.

Authors:  A L Ford; A L Goodsall; W F Hickey; J D Sedgwick
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

8.  CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.

Authors:  Christophe Combadière; Charles Feumi; William Raoul; Nicole Keller; Mathieu Rodéro; Adeline Pézard; Sophie Lavalette; Marianne Houssier; Laurent Jonet; Emilie Picard; Patrice Debré; Mirna Sirinyan; Philippe Deterre; Tania Ferroukhi; Salomon-Yves Cohen; Dominique Chauvaud; Jean-Claude Jeanny; Sylvain Chemtob; Francine Behar-Cohen; Florian Sennlaub
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Microglia-specific localisation of a novel calcium binding protein, Iba1.

Authors:  D Ito; Y Imai; K Ohsawa; K Nakajima; Y Fukuuchi; S Kohsaka
Journal:  Brain Res Mol Brain Res       Date:  1998-06-01

10.  Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.

Authors:  Leying Zhang; Darya Alizadeh; Michelle Van Handel; Marcin Kortylewski; Hua Yu; Behnam Badie
Journal:  Glia       Date:  2009-10       Impact factor: 7.452

View more
  69 in total

Review 1.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 2.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

Review 3.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

4.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

5.  Microglia in the tumor microenvironment: taking their TOLL on glioma biology.

Authors:  David H Gutmann
Journal:  Neuro Oncol       Date:  2014-12-18       Impact factor: 12.300

6.  An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possibe interventions in the cellular senescence and microglial pathways (an American Ophthalmological Society thesis).

Authors:  J Douglas Cameron; Fausto J Rodriguez; Elisabeth Rushing; Iren Horkayne-Szakaly; Charles Eberhart
Journal:  Trans Am Ophthalmol Soc       Date:  2014

7.  Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.

Authors:  Berenice Ortiz; Armida W M Fabius; Wei H Wu; Alicia Pedraza; Cameron W Brennan; Nikolaus Schultz; Kenneth L Pitter; Jacqueline F Bromberg; Jason T Huse; Eric C Holland; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

8.  RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease.

Authors:  Anne C Solga; Winnie W Pong; Jason Walker; Todd Wylie; Vincent Magrini; Anthony J Apicelli; Malachi Griffith; Obi L Griffith; Shinichi Kohsaka; Gregory F Wu; David L Brody; Elaine R Mardis; David H Gutmann
Journal:  Glia       Date:  2014-09-24       Impact factor: 7.452

9.  Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.

Authors:  Winnie W Pong; Samantha B Higer; Scott M Gianino; Ryan J Emnett; David H Gutmann
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

Review 10.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.